When the Body Knows Something Is Wrong
Tens of thousands of women have reported the same experience: implants placed, followed months or years later by fatigue that doesn't resolve, cognitive changes, joint pain, hair loss, rashes, depression, and a growing list of symptoms that physicians — running standard labs, finding nothing obviously wrong — attribute to stress, anxiety, or the inevitable aging process. Meanwhile, the implants remain in place, and the symptoms continue.
Breast Implant Illness (BII) is the name given to this constellation of systemic symptoms believed to be caused or contributed to by breast implants. For years, it existed outside official medicine — documented in patient forums, reported to the FDA in thousands of Medical Device Reports, and dismissed in clinical settings. In August 2019, the FDA formally acknowledged BII in its communications to manufacturers and the public, requiring it to be listed on device labeling. That acknowledgment arrived after decades of women being told their symptoms were psychological.
This page does not argue that every case of fatigue in a woman with implants is caused by the implants. It argues that the relationship between breast implants and systemic symptoms deserves serious clinical attention — the kind of attention that was structurally unavailable as long as BII was denied to exist at all.
What the FDA Acknowledged — and When
In October 2021, the FDA issued its most comprehensive action on breast implants to date, requiring manufacturers to add a boxed warning — the most serious warning the FDA places on medical devices — to breast implant labeling. The required language includes acknowledgment of:
- • Breast Implant Illness (BII) — a variety of systemic symptoms that may include fatigue, cognitive dysfunction, muscle and joint pain, rash, and depression
- • Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) — a type of non-Hodgkin lymphoma associated with breast implants (particularly textured surface implants)
- • Breast Implant-Associated Squamous Cell Carcinoma (BIA-SCC) — a rare cancer also identified in association with implants
- • A checklist requirement: patients must sign an informed consent checklist confirming they received and reviewed specific safety information
The boxed warning and patient decision checklist represent a formal medical acknowledgment that the informed consent historically provided for breast implant surgery was insufficient. Women were not being told what the FDA now requires them to be told. For women who had implants placed before 2021 — which is the majority of women with implants — that information was never provided.
BIA-ALCL: The Cancer No One Mentioned at Consultation
Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is a type of T-cell non-Hodgkin lymphoma that develops in the tissue and fluid surrounding breast implants. It is not breast cancer. It is a lymphoma of the breast pocket. As of current FDA tracking, hundreds of confirmed cases have been reported globally, with the majority associated with textured surface implants — implants with a rough outer shell, originally designed to reduce capsular contracture.
BIA-ALCL is not common in absolute terms. But it is a cancer that develops specifically in women with implants and that was not disclosed as a risk until the FDA's 2019 and 2021 safety communications. Women who had textured implants placed before that disclosure were never told this risk existed. Textured implants have been banned or restricted in several countries, including France, Canada, and members of the EU.
Signs That May Indicate BIA-ALCL
- • Late seroma — fluid collection around the implant, appearing months to years after surgery (not at the time of surgery)
- • Unexplained swelling or asymmetry in one breast
- • A mass in the breast or armpit
- • If diagnosed, requires consultation with an oncologist alongside a plastic surgeon — not a surgical revision alone
BIA-ALCL requires prompt evaluation. If you develop unexplained late seroma with textured implants, do not wait.
Breast Implant Illness: The Symptom Pattern
BII does not have a single diagnostic test or a single universally accepted mechanism. What it has is a documented, consistent pattern of symptoms reported across thousands of women, across implant types, materials, and manufacturers — that frequently resolves following explant surgery. The symptom constellation is broad and overlaps with autoimmune conditions, thyroid disease, chronic fatigue syndrome, fibromyalgia, and neurological disorders — which is part of why it has been so consistently missed.
Commonly Reported Symptoms
The autoimmune overlap is clinically significant. Multiple studies have now found elevated rates of autoimmune conditions — including Sjögren's syndrome, rheumatoid arthritis, systemic lupus, and mixed connective tissue disease — in women with breast implants compared to the general population. A 2018 study published in Annals of Surgery (Coroneos et al.) found statistically elevated rates of several autoimmune and connective tissue diseases in women with silicone gel implants.
Why Implants Can Cause Systemic Symptoms: Proposed Mechanisms
The mechanism of BII is not fully established, which is part of why it remained unrecognized for so long. Several biological pathways have been proposed and are supported by varying levels of evidence.
Silicone Gel Bleed
Silicone gel implants leak silicone molecules through an intact shell — a phenomenon called "gel bleed." This has been documented through both histological and spectroscopic analysis. Silicone particles migrate to regional lymph nodes, liver, and other tissues. The immune system's response to silicone in tissues — whether acute or chronic, local or systemic — is an area of ongoing research and clinical debate.
Implant Shell Degradation and Leachables
The outer shell of silicone implants — and the contents of both silicone and saline implants — contain a range of chemical compounds: platinum (used as a catalyst in silicone manufacturing), cyclomethicones, heavy metals in trace amounts, and other materials. As implants age, the shell can degrade and these compounds can leach into surrounding tissue. Platinum, in particular, is detectable in the urine and hair of some women with implants.
Capsular Contracture and Chronic Inflammation
The body forms a fibrous capsule around any foreign material — including implants. Capsular contracture occurs when this capsule thickens and tightens around the implant. Even without visible contracture, the capsule represents a chronic low-grade inflammatory environment. Chronic systemic inflammation has downstream effects on every body system: hormonal, neurological, immune, metabolic.
Biofilm and Bacterial Colonization
A biofilm — a community of microorganisms enclosed in a protective matrix — can form on implant surfaces. Biofilm-associated infections can be low-grade, sub-clinical, and difficult to detect on standard cultures, while maintaining a chronic immune-activating environment. Some researchers have proposed that biofilm may explain some of the systemic immune dysregulation seen in BII.
Immune Dysregulation and Molecular Mimicry
Some researchers have proposed that silicone or implant-associated proteins may trigger immune responses through molecular mimicry — where the immune system's response to foreign material cross-reacts with the body's own tissues, producing autoimmune-like symptoms. This is consistent with the clinical observation that BII symptoms frequently overlap with recognized autoimmune conditions.
EMF, Mold Inside Saline Implants, and Water Memory: The Layers Nobody Mentioned
Beyond the documented mechanisms of gel bleed and chemical leaching, there are additional compounding factors that clinical practitioners working with BII patients have observed — factors that are rarely discussed in conventional settings because they fall outside the standard biomedical framework. They deserve to be named.
Mold Inside Saline Implants
Saline implants are filled with sterile saline solution at the time of implantation. The filling valve is then sealed — but over time, that valve can degrade, allowing trace amounts of biological material to migrate into the saline cavity. The interior of a saline implant is a warm, dark, enclosed environment with no circulation — ideal conditions for microbial growth if the barrier is compromised.
Mold and fungal growth have been documented inside saline implants in clinical case reports. Women with unexplained neurological symptoms, respiratory problems, or severe chronic illness — who had not improved despite treatment and who explanted — have had mold identified inside their implants upon removal. The biological material is enclosed within the implant shell and not detectable by external imaging. Standard laboratory testing does not assess for this. It can only be discovered by opening the implant after removal and culturing the contents — which is not routinely done unless specifically requested.
Request This at Explant
Ask your explant surgeon to send the implant contents — not just the capsule — to a laboratory for analysis, including fungal culture. This is a straightforward request that is rarely offered but provides important information about what has been living inside your implant.
EMF and Implants: RF Radiation in a Conductive Saline Environment
Saline is electrically conductive. A saline-filled implant sitting within the body — which is itself a conductive medium — exists within the RF-EMF fields generated by the phones, smart watches, laptops, and routers that surround it daily. RF-EMF creates oscillating electrical fields in conductive tissue and fluid. A saline implant in that field may interact with radiation differently than surrounding tissue — concentrating or altering the pattern of electrical disturbance in ways that have not been systematically studied.
What is documented is that RF-EMF affects biological tissue — activating voltage-gated calcium channels, increasing oxidative stress, and disrupting cellular repair during sleep. For women with implants, the precautionary principle is not optional. The breast is not an appropriate location to store a transmitting device.
EMF Precautions — Non-Negotiable for Women with Implants
No phones in the bra — ever
A phone resting against breast tissue is transmitting RF radiation at maximum antenna proximity. The phone-in-bra case series documented multifocal tumors precisely at contact points in young women with no genetic risk factors. With implants, there is the additional concern of the conductive saline environment.
No smart watches
Smart watches emit Bluetooth and cellular signals continuously — against the wrist, all day. There is no safe position for a wireless transmitter worn on the body. Do not wear a smart watch.
No sleeping with a phone near the body
Sleep is the primary window for cellular repair and immune activity. A phone on the nightstand, under the pillow, or on the bed transmits throughout the night — disrupting the repair window when it is most needed. Phone goes on airplane mode or out of the room entirely. No exceptions.
No working near a WiFi router
WiFi routers broadcast continuously at 2.4 GHz and 5 GHz. Working with a router within 3–6 feet — on a desk, on a shelf in the room, mounted to a wall nearby — creates sustained daily exposure to the chest area. Hardwire with ethernet and disable the router's WiFi radio. If you cannot hardwire, move the router to a different room and extend via powerline adapter or wired access point.
No phone on the body — pockets, waistband, or held against the chest
A phone in a front pocket sits near the abdomen and lower chest. Held flat against the chest during a call or laid on the chest while lying down, it is in direct proximity to breast tissue. Apple's own fine print states a minimum separation of 5mm from the body. In practice, phones are worn against skin. Use a bag or purse — not your body — as the carry location.
The car is not a safe EMF environment
A car is a partial Faraday cage — metal body, windows, enclosed space. RF signals from your phone, the car's built-in cellular and WiFi systems, Bluetooth, and hotspot broadcasting bounce and concentrate inside the cabin rather than dissipating. Bluetooth is not a necessity. A hotspot is not a necessity. These are habits, not requirements. For someone who is sick, the options for optional tech use are gone — phone on the dash or in a bag, airplane mode when not actively navigating, car Bluetooth and hotspot off, no streaming. The question is not "when do I need it" — it is "do I actually need it at all."
For measurement: An Acoustimeter AM-10 or similar RF meter will show you what is actually transmitting in your environment and at what levels. Measure your desk, your bed, your car interior. The numbers make the abstract concrete — and make it much easier to prioritize what to change first. See the Apothecary EMF section and the full Non-Native EMF module for the complete evidence base and mitigation guide.
EMF, Mold, and the Amplification Pattern
Research in environmental and biological science has indicated that certain frequencies of electromagnetic fields appear to stimulate mold growth, increase mold toxin (mycotoxin) production, and accelerate fungal sporulation. If mold is present inside a saline implant — or in the surrounding capsule environment — chronic EMF exposure from devices worn or carried close to the body may worsen the biological burden of that mold presence.
This is an area of emerging investigation rather than established consensus. But it is consistent with clinical observations in practitioners working with mold-illness patients: those with high EMF environments frequently show more severe mold-related symptoms than those without. Reducing EMF exposure is a standard recommendation in mold illness recovery protocols — and is particularly relevant for BII patients whose symptom picture includes cognitive dysfunction, fatigue, and inflammatory presentations consistent with biotoxin illness.
Water Memory and the Environment of the Implant
The work of Dr. Masaru Emoto and Dr. Luc Montagnier has raised the question of whether water retains information from its environment — a concept referred to as water memory. Emoto's crystallography research documented that water exposed to different environmental conditions (including chaotic electromagnetic environments, pollution, and emotional disturbance) formed distorted crystal structures, while water in coherent, clean environments formed organized, symmetrical crystals.
Applied to saline implants: the water inside a saline implant sits, for years, in a chronic inflammatory environment — surrounded by the body's immune response, exposed to whatever EMF fields the woman's daily life generates, and in some cases potentially harboring microbial growth. If water retains structural memory of its environment — as this body of research suggests — the biological state of that water after years in an implant cavity may be meaningfully different from the sterile saline that went in. This is a framework that requires more research. It is consistent with the broader evidence that the quality, structure, and electromagnetic environment of water affects its biological activity — see the Water page for more on water structuring and biological function.
Better Testing: Going Beyond the Standard Workup
Standard blood work — CBC, CMP, TSH — does not adequately assess the complex immune, inflammatory, and toxic burden picture in women with suspected BII. A more comprehensive approach, as documented by practitioners specializing in BII (including Cheyenne Burnett's Explant Secrets resources), includes the following.
Structural Integrity Assessment
- • Breast MRI without contrast — the gold standard for assessing implant integrity; can detect silent rupture and gel migration. Avoid gadolinium contrast if possible (gadolinium deposits in brain tissue — see Pharmacology Library).
- • Ultrasound — useful for detecting fluid (seroma) around the implant; less sensitive than MRI for shell integrity
Inflammatory & Autoimmune Panel
- • ANA (antinuclear antibody) — screening for systemic autoimmune activity
- • Anti-dsDNA, anti-Sm, anti-SSA/SSB, anti-Scl-70, anti-Jo-1 — specific autoantibodies for lupus, Sjögren's, scleroderma
- • ESR (erythrocyte sedimentation rate) and CRP (C-reactive protein) — nonspecific inflammatory markers
- • Complement C3/C4 — may be low in active autoimmune disease
- • Complete lymphocyte panel (CD4/CD8 T-cell ratios) — immune dysregulation marker
- • NK cell activity — natural killer cell function, often suppressed in chronic illness
Toxic & Heavy Metal Burden
- • Urine heavy metals panel (provoked or unprovoked) — platinum, titanium, aluminum, mercury; implant degradation products
- • Hair tissue mineral analysis (HTMA) — chronic exposure pattern over months
- • Organic acids test — mitochondrial function, detoxification capacity, gut dysbiosis markers
Hormonal & Metabolic Assessment
- • Full thyroid panel (TSH, free T3, free T4, reverse T3, thyroid antibodies TPO and TG) — BII frequently presents with thyroid involvement
- • Complete sex hormone panel (estradiol, progesterone, testosterone, DHEA-S, SHBG)
- • Cortisol diurnal curve (4-point salivary) — adrenal axis function
- • Insulin, fasting glucose, HbA1c — metabolic inflammation
Specialized Testing (Where Available)
- • Lymphocyte Transformation Test (LTT) — tests immune reactivity to specific materials including silicone; not universally available
- • MELISA test — an advanced version of LTT used in Europe to assess immune reactivity to metals and silicone
- • Silicone antibody testing — available through specialty labs; tests immune response to silicone compounds
Explant: What "Removal" Actually Means
Not all implant removal is equal. When an implant is removed without the surrounding capsule, silicone particles, gel bleed residue, and any biofilm-contaminated tissue remain in the body. For women with BII, the type of removal matters significantly for recovery outcomes.
Standard Removal / Simple Capsulectomy
The implant is removed. The capsule may be partially removed or left in place. Any silicone that has migrated beyond the capsule remains. Many BII patients who undergo standard removal report incomplete symptom resolution.
En Bloc Capsulectomy
The implant and its surrounding capsule are removed together, intact — preventing spillage of capsule contents and any trapped silicone, bacteria, or reactive tissue into the surgical field. This is the preferred approach for BII and ruptured implants. Requires a surgeon specifically trained and experienced in this technique. Not all plastic surgeons perform en bloc removal.
Questions to Ask a Prospective Explant Surgeon
- • "Do you perform en bloc capsulectomy? How many have you done?"
- • "Will you remove the entire capsule intact, or will you open the capsule during removal?"
- • "What is your protocol if you find a ruptured implant or capsule adhesion to surrounding tissue?"
- • "Will you send the capsule to pathology for assessment including BIA-ALCL testing?"
- • "What does your post-operative support look like for patients with BII?"
Supporting Recovery After Explant
Many women report significant symptom improvement in the weeks and months following en bloc explant. Recovery is a process — the body's detoxification capacity, immune system, and hormone axes all need support after years of chronic inflammation and toxic burden. But the order in which you approach recovery matters enormously.
Establish Redox Before You Detox
The most common mistake in BII recovery is pushing aggressive detox protocols on a body that does not yet have the cellular energy to handle them. Mobilizing stored toxins — silicone particles, heavy metals, chemical residues — without adequate detoxification capacity means those toxins circulate and redistribute rather than clear. This can make a sick body sicker.
Redox refers to your body's reduction-oxidation capacity — its ability to produce cellular energy (ATP), neutralize oxidative stress, and run the enzymatic reactions that detoxification depends on. A body depleted by years of chronic inflammation, poor sleep, EMF exposure, and nutrient deficiency has impaired redox capacity. Attempting to detox this body aggressively is like trying to run a drainage system with no pump.
Establish the foundation first:
- ●EMF environment — the sleep environment is the most critical space. This means more than phones and routers. Metal bed frames concentrate fields. Power cords run under mattresses. Heating pads, electric blankets, magnets, and pulse devices sit on or near the body for hours. Smart meters on exterior bedroom walls, AC units near the head, and bad wiring inside the walls all contribute. The goal is a biologically quiet sleep space. Cellular repair happens during deep sleep — it cannot proceed in a field of non-native EMF. Start here. See the EMF page for a complete audit guide.
- ●Lighting — remove LED lighting from the home where possible and replace with low-wattage 2700K incandescent bulbs. No artificial light after dark, or as little as possible. Seeing the sunrise daily is non-negotiable — this is the signal that sets every hormonal cascade that follows. No glasses, no sunscreen, eyes toward the sky. The safest approach after dark is simply lowering light — melanopsin receptors in the skin respond to light, not just the eyes, so glasses alone do not fully protect melatonin. Blue-blocking glasses (550nm) can help if some light is unavoidable, but they are not a substitute for reducing light exposure itself. These are free interventions that restore the hormonal architecture repair depends on.
- ●Water — drink spring water. Natural spring water carries coherent structure, minerals, and biological information that no filtered or processed source replicates. Find a local spring at findaspring.com and test before drinking. Commercially bottled spring water is acceptable — even in plastic — over RO or tap. RO water is dead water; adding minerals or Quinton back in addresses minerals but does not restore coherence, and is not the recommendation. For additional coherence and structuring, place your water on a YouMatrix H2O disk before drinking. Use filtration (whole-house carbon or RO) for bathing and showering — not for drinking. Intracellular hydration is a prerequisite for every detoxification pathway.
- ●Real whole food — practitioner-guided. Most women in active BII are highly reactive. What works for a healthy body may aggravate a compromised one. Avoid processed seed oils, refined sugar, alcohol, and packaged foods. Beyond that, individual food reactions vary significantly and are best worked through with a practitioner who knows your case. The liver runs phase I and phase II detoxification — it requires real food, not restriction. Nourish, do not restrict. If you are unsure where to start, work with someone who can guide you through the reactivity.
- ●Rest — not pushing — a depleted body signals through fatigue. Honor that signal. Aggressive exercise, aggressive protocols, and aggressive supplement stacks during this phase worsen mitochondrial burden. Gentle movement, walking, lymphatic support, and rest are appropriate. The body is doing the heavy work internally.
The Body Is Designed to Drain — Create the Conditions
The body does not need to be forced through detoxification. It needs the conditions that allow it to drain on its own. When EMF is reduced, circadian rhythm is restored, sleep is deep, and water is coherent and structured, the body's innate drainage systems come back online. Attempting to force heavy metal clearance or mold detox protocols on a body that has not yet reached this baseline can make things significantly worse — mobilizing stored toxins faster than elimination pathways can handle them, causing redistribution, increased symptom burden, and systemic aggravation.
The foundation is the protocol. Coherence, circadian alignment, low EMF, and structured spring water are not preparation for detox — they are the mechanism. The body was built to do this work when the interference is removed.
- ●Liver support through food — adequate real food, sulfur-rich vegetables (onions, garlic, cruciferous vegetables), clean structured spring water. The liver requires fuel and cofactors, not stimulants or aggressive binders.
- ●Lymphatic movement — gentle walking, manual lymphatic drainage massage, deep diaphragmatic breathing. The lymphatic system has no pump of its own — movement is the pump. This is supportive, not aggressive.
- ●Spring water — local or commercially bottled (findaspring.com). Use a YouMatrix H2O disk for additional structuring and coherence. Every drainage pathway in the body is water-dependent.
- ●Practitioner support — if you are not moving through recovery or need more targeted support, working with a practitioner who has access to the YouMatrix tools and protocols may offer another level of assistance. These tools work with the body's coherence and field — not against it.
Warning: Supplemental Glutathione & Breast Cancer Metastasis
Glutathione is widely recommended in detoxification and BII recovery protocols. However, research has documented that elevated glutathione levels can promote breast cancer cell survival and metastasis — glutathione's antioxidant activity protects cancer cells from the oxidative stress that would otherwise destroy them, and facilitates their migration and invasion of surrounding tissue. This is not a theoretical concern. It is a documented mechanism with direct relevance to any woman with a history of breast implants, who carries elevated breast cancer risk, or who has not yet completed comprehensive imaging to rule out malignancy.
Do not supplement with liposomal glutathione, NAC (as a glutathione precursor), or glutathione IV therapy without a full workup and practitioner oversight that includes ruling out active cancer. Support glutathione through whole foods only — cruciferous vegetables (broccoli, cauliflower, Brussels sprouts), alliums (garlic, onions), and liver — where it is delivered with the complete matrix of co-factors that regulate its activity rather than as a concentrated isolated supplement.
Warning: Chlorella Can Make a Sick Body Sicker
Chlorella is commonly recommended as a heavy metal binder and detoxification support. In a compromised, depleted body — which describes most women in active BII — chlorella can mobilize more toxins than the elimination pathways can handle, causing increased symptom burden, headache, fatigue, and systemic aggravation. It can also cause immune reactions in people with mold or algae sensitivities. Some women in BII recovery may never tolerate chlorella at all, regardless of where they are in the process. Moringa is a gentler option worth exploring — it supports detoxification pathways, provides a broad nutrient profile, and is better tolerated by reactive individuals. Neither is a starting point. Work with a practitioner before introducing either.
Immune Regulation and Inflammation
- • Real whole food — the clearest guideline is to remove the industrial inputs: processed seed oils, refined sugar, alcohol, and packaged foods. What remains is real food. Eat it. The amounts and ratios that work for your body are individual — macro prescriptions and glucose anxiety cause their own harm, and 30 years of clinical practice shows that eating disorders, orthorexia, and over-restriction do as much damage as the food itself. Nourish, do not restrict. If EMF, sleep deprivation, and lack of sunlight are still in the picture, they are dysregulating metabolism more than any real food choice — address the environment alongside the food.
- • Gut microbiome restoration — fermented foods, prebiotic fibers; the gut-immune axis is central to autoimmune recovery
- • Sleep — the single most powerful immune-regulatory intervention; 7–9 hours in a dark, low-EMF environment
- • Sunlight — morning light for cortisol curve normalization and circadian reset; midday UVB for skin-produced vitamin D (not supplemental isolated vitamin D)
Hormonal Recovery
BII is frequently associated with thyroid and adrenal dysfunction — both from the chronic inflammatory burden and from xenoestrogenic and immune effects of implant materials. Comprehensive hormonal assessment (as described in the testing section above) should inform any targeted support. See the HRT & Hormone Disruptors page for the full framework on hormonal recovery, estrogen dominance, and adrenal support.
— Cheyenne Burnett, Explant Secrets Podcast, Episode 6: Your Essential Testing Guide for BII
Studies, Podcasts & Resources
Essential Listening & Community
Explant Secrets Podcast — Cheyenne Burnett
TEDx speaker and Women's Health Warrior. Episode 6 "Your Essential Testing Guide: Testing for Breast Implant Illness" is a comprehensive resource on comprehensive testing beyond standard blood work. Community at Explant Secrets Facebook Group.
explantsecrets.com/podcast →Explant Secrets YouTube & Instagram
Video content on BII, testing, explant surgery, and recovery. @explantsecretspodcast on Instagram.
YouTube →Key Studies
Coroneos et al. — Breast Implants & Autoimmune Disease (Annals of Surgery, 2019)
FDA-commissioned study; 100,000+ women with silicone gel implants. Elevated rates of autoimmune and connective tissue disorders confirmed statistically. Sjogren's, rheumatoid arthritis, systemic lupus, scleroderma, and others.
PubMed →FDA Safety Communication — BIA-ALCL (2019) & Boxed Warning (2021)
FDA's formal acknowledgment of BIA-ALCL risk and BII. Required boxed warning and patient decision checklist now mandatory for all breast implant procedures. Full device labeling requirements.
FDA.gov Breast Implant Risks →Breast Implant Illness — Systematic Review (Hindawi, 2022)
Characterizes BII autoimmune disorders and associated symptoms across the current literature. Confirms BII as a recognized clinical entity with documented autoimmune overlap.
Full Text (Hindawi) →Finding an En Bloc Surgeon
Breast Implant Safety Alliance (BISA)
Surgeon directory and patient resources for finding practitioners who specialize in en bloc capsulectomy for BII. Patient advocacy and informed consent resources.
thebreastimplantsafetyalliance.org →Related Pages
Mammograms & Breast Health
Mammogram overdiagnosis, false positives, dense breast tissue, phone-in-bra case series, and what to ask your radiologist.
Breast Health page →Hormone Disruptors & HRT
Hormonal recovery framework, estrogen dominance, and adrenal support — relevant to post-explant hormonal recovery.
HRT & Bioidentical Hormones →Drug Reference Library — Contrast Agents
Gadolinium deposition from MRI contrast — relevant for women considering MRI to assess implant integrity; request non-contrast breast MRI where possible.
Pharmacology Library →Video Transcript
Estimated runtime: ~3:30–4:00
Video in Production
This video is currently being filmed. The full transcript is below — all the information is here while you wait.
For years, tens of thousands of women reported the same experience. They got breast implants. And then — months, sometimes years later — they weren't well. Fatigue they couldn't explain. Brain fog. Joint pain. Hair loss. Rashes. Depression. They went to doctors. They ran standard labs. They were told everything was normal. The implants were fine. The symptoms were probably stress.
In 2021, the FDA required that every breast implant manufacturer add a boxed warning — the most serious warning designation on a medical device — acknowledging that breast implants are associated with systemic symptoms including fatigue, cognitive dysfunction, joint pain, and depression. That acknowledgment did not come from nowhere. It came from the women who had been documenting this for decades.
The FDA's action covered two things. First, Breast Implant Illness — the systemic symptom picture I just described. Second, BIA-ALCL: Breast Implant-Associated Anaplastic Large Cell Lymphoma. This is a lymphoma — not breast cancer — that develops in the tissue around breast implants. It's primarily associated with textured surface implants, which have now been banned or restricted in France, Canada, and several EU countries. The United States still permits them.
The informed consent checklist now required by the FDA means that women getting implants today must be told these risks before surgery. Women who had implants placed before that — the majority of women with implants — were never told any of it. They consented to a procedure without information the FDA now considers essential.
Breast Implant Illness is a systemic condition. The symptoms are broad: fatigue, brain fog, joint and muscle pain, hair loss, dry eyes, rashes, depression, thyroid dysfunction, autoimmune-like presentation. They overlap with lupus, Sjögren's syndrome, fibromyalgia, chronic fatigue. Which is exactly why standard workups miss it — because no single test result, no ANA, no thyroid panel, captures the whole picture.
Research published in the Annals of Surgery — an FDA-commissioned study of over 100,000 women with breast implants — found statistically elevated rates of connective tissue disease, autoimmune conditions, and inflammatory disorders compared to the general population. This is peer-reviewed data. It is not a forum post.
The mechanisms include silicone gel bleed through an intact shell, implant shell degradation and chemical leaching, chronic inflammation from the fibrous capsule the body forms around any foreign object, and possibly biofilm — low-grade bacterial colonization on implant surfaces that maintains a chronic immune-activating environment without producing the kind of obvious infection that standard tests detect.
Standard blood work doesn't adequately evaluate BII. A comprehensive workup includes a full autoimmune panel — ANA, specific autoantibodies — inflammatory markers, complete thyroid and hormone assessment, organic acids test, and heavy metals. MRI without contrast is the gold standard for assessing whether your implants are structurally intact. And there are specialized tests — lymphocyte transformation testing, silicone antibody testing — that assess immune reactivity to the specific materials in your implants.
If you decide to explant, what type of removal matters enormously. Standard removal leaves the capsule — and everything in it — behind. En bloc capsulectomy removes the implant and the entire surrounding capsule intact, in one piece, preventing any spillage of capsule contents into the surgical field. Women with BII who report significant improvement after explant have almost universally undergone en bloc removal, not standard.
Not every surgeon performs en bloc. Ask directly. Ask how many they have done. If the answer is vague, find someone who specializes.
Recovery from BII is a process. Many women feel dramatic improvement within weeks of explant. For others, it takes longer — the body's detoxification of silicone, chemical residues, and the chronic inflammatory burden from years of BII takes time and support. Liver support. Lymphatic drainage. Heavy metal clearance under clinical guidance. Gut restoration. Hormonal recovery — thyroid and adrenal function both commonly need support post-explant.
This is not a simple medical procedure followed by a quick return to normal. It is a whole-body recovery. Treating it that way — with the support your physiology actually needs — makes a difference.
If you have implants and you have not been well — in ways that your doctors have not been able to explain — BII deserves to be on the differential. Not because implants cause problems in every woman. But because the FDA now formally acknowledges that they cause problems in some women. And because the women who documented this for decades before the FDA caught up — who were dismissed, who were told their symptoms were in their head — deserve to have their experience taken seriously. The resources are in the Resources tab. The testing guide is in the written article. Start there.